Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Buy
53
MEDP Quote, Financials, Valuation and Earnings
Last price:
$549.22
Seasonality move
:
3.24%
Day range:
$541.02 - $552.60
52-week range:
$250.05 - $626.26
Dividend yield:
0%
P/E ratio:
38.41x
P/S ratio:
7.05x
P/B ratio:
52.68x
Volume:
216.9K
Avg. volume:
279.6K
1-year change:
56.67%
Market cap:
$15.5B
Revenue:
$2.1B
EPS (TTM):
$14.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$641M | $3.57 | 28.48% | 14.57% | $538.58 |
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.72% | 105.56% | $126.48 |
|
BTSG
BrightSpring Health Services, Inc.
|
$3.2B | $0.26 | 10.83% | 365.95% | $40.31 |
|
CRL
Charles River Laboratories International, Inc.
|
$990.8M | $2.34 | -1.55% | 75.74% | $189.27 |
|
FTRE
Fortrea Holdings, Inc.
|
$643.2M | $0.16 | -4.77% | -94.16% | $11.25 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.4B | $1.99 | 12.86% | 18.99% | $596.36 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$549.17 | $538.58 | $15.5B | 38.41x | $0.00 | 0% | 7.05x |
|
BSX
Boston Scientific Corp.
|
$93.84 | $126.48 | $139.1B | 50.19x | $0.00 | 0% | 7.24x |
|
BTSG
BrightSpring Health Services, Inc.
|
$34.54 | $40.31 | $6.2B | 57.65x | $0.00 | 0% | 0.60x |
|
CRL
Charles River Laboratories International, Inc.
|
$187.12 | $189.27 | $9.2B | 913.13x | $0.00 | 0% | 2.33x |
|
FTRE
Fortrea Holdings, Inc.
|
$14.78 | $11.25 | $1.4B | -- | $0.00 | 0% | 0.48x |
|
ISRG
Intuitive Surgical, Inc.
|
$566.89 | $596.36 | $201B | 75.04x | $0.00 | 0% | 21.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
32.9% | 1.304 | 0.99% | 0.51x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
BTSG
BrightSpring Health Services, Inc.
|
59.75% | 3.568 | 50.52% | 0.74x |
|
CRL
Charles River Laboratories International, Inc.
|
43.59% | 1.998 | 33.97% | 0.85x |
|
FTRE
Fortrea Holdings, Inc.
|
67.15% | 2.935 | 152.94% | 0.92x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.065 | -- | 3.42x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$189.9M | $141.8M | 61.64% | 78.26% | 21.49% | $235.5M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
BTSG
BrightSpring Health Services, Inc.
|
$392M | $105.5M | 1.57% | 4.14% | 3.17% | $92.2M |
|
CRL
Charles River Laboratories International, Inc.
|
$324.7M | $151.1M | -1.27% | -2.28% | 15.04% | $178.2M |
|
FTRE
Fortrea Holdings, Inc.
|
$103.1M | -$3.7M | -46.62% | -104.76% | -0.53% | $79.5M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
Medpace Holdings, Inc. vs. Competitors
-
Which has Higher Returns MEDP or BSX?
Boston Scientific Corp. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 14.91%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About MEDP or BSX?
Medpace Holdings, Inc. has a consensus price target of $538.58, signalling downside risk potential of -1.93%. On the other hand Boston Scientific Corp. has an analysts' consensus of $126.48 which suggests that it could grow by 34.79%. Given that Boston Scientific Corp. has higher upside potential than Medpace Holdings, Inc., analysts believe Boston Scientific Corp. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 BSXBoston Scientific Corp.25 2 0 -
Is MEDP or BSX More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.
-
Which is a Better Dividend Stock MEDP or BSX?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or BSX?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Medpace Holdings, Inc.'s net income of $111.1M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 38.41x while Boston Scientific Corp.'s PE ratio is 50.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.05x versus 7.24x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.05x 38.41x $659.9M $111.1M BSXBoston Scientific Corp.7.24x 50.19x $5.1B $755M
-
Which has Higher Returns MEDP or BTSG?
BrightSpring Health Services, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 1.12%. Medpace Holdings, Inc.'s return on equity of 78.26% beat BrightSpring Health Services, Inc.'s return on equity of 4.14%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M BTSGBrightSpring Health Services, Inc.11.76% $0.26 $4.5B -
What do Analysts Say About MEDP or BTSG?
Medpace Holdings, Inc. has a consensus price target of $538.58, signalling downside risk potential of -1.93%. On the other hand BrightSpring Health Services, Inc. has an analysts' consensus of $40.31 which suggests that it could grow by 16.7%. Given that BrightSpring Health Services, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe BrightSpring Health Services, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 BTSGBrightSpring Health Services, Inc.12 1 0 -
Is MEDP or BTSG More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison BrightSpring Health Services, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDP or BTSG?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BrightSpring Health Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. BrightSpring Health Services, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or BTSG?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than BrightSpring Health Services, Inc. quarterly revenues of $3.3B. Medpace Holdings, Inc.'s net income of $111.1M is higher than BrightSpring Health Services, Inc.'s net income of $37.5M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 38.41x while BrightSpring Health Services, Inc.'s PE ratio is 57.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.05x versus 0.60x for BrightSpring Health Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.05x 38.41x $659.9M $111.1M BTSGBrightSpring Health Services, Inc.0.60x 57.65x $3.3B $37.5M
-
Which has Higher Returns MEDP or CRL?
Charles River Laboratories International, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 5.53%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Charles River Laboratories International, Inc.'s return on equity of -2.28%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M CRLCharles River Laboratories International, Inc.32.32% $1.10 $6.1B -
What do Analysts Say About MEDP or CRL?
Medpace Holdings, Inc. has a consensus price target of $538.58, signalling downside risk potential of -1.93%. On the other hand Charles River Laboratories International, Inc. has an analysts' consensus of $189.27 which suggests that it could grow by 1.15%. Given that Charles River Laboratories International, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe Charles River Laboratories International, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 CRLCharles River Laboratories International, Inc.9 8 0 -
Is MEDP or CRL More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Charles River Laboratories International, Inc. has a beta of 1.633, suggesting its more volatile than the S&P 500 by 63.257%.
-
Which is a Better Dividend Stock MEDP or CRL?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Charles River Laboratories International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Charles River Laboratories International, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or CRL?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Charles River Laboratories International, Inc. quarterly revenues of $1B. Medpace Holdings, Inc.'s net income of $111.1M is higher than Charles River Laboratories International, Inc.'s net income of $55.6M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 38.41x while Charles River Laboratories International, Inc.'s PE ratio is 913.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.05x versus 2.33x for Charles River Laboratories International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.05x 38.41x $659.9M $111.1M CRLCharles River Laboratories International, Inc.2.33x 913.13x $1B $55.6M
-
Which has Higher Returns MEDP or FTRE?
Fortrea Holdings, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of -2.27%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Fortrea Holdings, Inc.'s return on equity of -104.76%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M FTREFortrea Holdings, Inc.14.7% -$0.17 $1.8B -
What do Analysts Say About MEDP or FTRE?
Medpace Holdings, Inc. has a consensus price target of $538.58, signalling downside risk potential of -1.93%. On the other hand Fortrea Holdings, Inc. has an analysts' consensus of $11.25 which suggests that it could fall by -23.85%. Given that Fortrea Holdings, Inc. has more downside risk than Medpace Holdings, Inc., analysts believe Medpace Holdings, Inc. is more attractive than Fortrea Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 FTREFortrea Holdings, Inc.1 8 0 -
Is MEDP or FTRE More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Fortrea Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDP or FTRE?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Fortrea Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Fortrea Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or FTRE?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Fortrea Holdings, Inc. quarterly revenues of $701.3M. Medpace Holdings, Inc.'s net income of $111.1M is higher than Fortrea Holdings, Inc.'s net income of -$15.9M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 38.41x while Fortrea Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.05x versus 0.48x for Fortrea Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.05x 38.41x $659.9M $111.1M FTREFortrea Holdings, Inc.0.48x -- $701.3M -$15.9M
-
Which has Higher Returns MEDP or ISRG?
Intuitive Surgical, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 28.31%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About MEDP or ISRG?
Medpace Holdings, Inc. has a consensus price target of $538.58, signalling downside risk potential of -1.93%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $596.36 which suggests that it could grow by 5.2%. Given that Intuitive Surgical, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe Intuitive Surgical, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 ISRGIntuitive Surgical, Inc.15 10 1 -
Is MEDP or ISRG More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock MEDP or ISRG?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or ISRG?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Medpace Holdings, Inc.'s net income of $111.1M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 38.41x while Intuitive Surgical, Inc.'s PE ratio is 75.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.05x versus 21.44x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.05x 38.41x $659.9M $111.1M ISRGIntuitive Surgical, Inc.21.44x 75.04x $2.5B $709.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
67
GPCR alert for Dec 9
Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.
Buy
62
SMX alert for Dec 9
SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.
Buy
90
KYMR alert for Dec 9
Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.
